Add Yahoo as a preferred source to see more of our stories on Google. PH is a progressive pulmonary vascular disease estimated to affect up to 1% of the global population. Credit: Orawan ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an ...
GlobalData on MSN
FDA approves Anumana’s pulmonary hypertension algorithm
The algorithm integrates with EHR systems and ECG platforms, operating within the health system without external data transfer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results